⌘K

Login Start Free

Home/Filings/4/0001225208-20-013614

4//SEC Filing

LORANGER STEVEN R 4

Accession 0001225208-20-013614

CIK 0001099800other

View on SEC.gov Company Profile

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 6:50 PM ET

Size

7.5 KB

Accession

0001225208-20-013614

Insider Transaction Report

Form 4

Period: 2020-11-16

Edwards Lifesciences CorpEW

LORANGER STEVEN R

Director

Transactions

Exercise/Conversion
Director Stock Option (Right to Acquire)
2020-11-16−19,797→ 0 total
Exercise: $35.20From: 2017-05-12Exp: 2023-05-11→ Common Stock (19,797 underlying)
Exercise/Conversion
Common Stock
2020-11-16$35.20/sh+19,797$696,789→ 46,965 total

Holdings

Common Stock
(indirect: By Trust)
15,000

Documents

1 file

4
doc4.xmlPrimary

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeother

Related Parties

1

filerCIK 0001226924

Filing Metadata

Form type: 4
Filed: Nov 16, 7:00 PM ET
Accepted: Nov 17, 6:50 PM ET
Size: 7.5 KB

View on SEC.gov